Sustainability Considerations For Drug Delivery Device End-To-End Solutions

By Barbara Lead, CEO of Cambridge Pharma Ltd and Oval Medical Technologies

At last year's COP26 summit held in Glasgow, further cuts to carbon dioxide emissions were agreed to accelerate action on climate change over this decade. The aim is to keep average global temperature increases to less than 1.5°C, as recommended by scientists say to prevent a "climate catastrophe." Beyond legislative requirements businesses must innovate and act smartly to support this objective.

The SMC Group of associated businesses are mindful of this. In this article, Barbara Lead, the CEO of Cambridge Pharma Ltd and Oval Medical Technologies, sets out to share how they are looking to address the gradual unlinking of economic activity from consumption of finite resources and removal of waste to support and help prevent a global climate catastrophe.

Reviews several ways of minimizing the carbon footprint of a drug delivery device.